補助人工心臓治療チーム実践ガイド　改訂第2版

出版社： メジカルビュー社
著者：
発行日： 2018-11-10
分野： 臨床医学：内科  >  循環器一般
ISBN： 9784758319515
電子書籍版： 2018-11-10 （第2版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

8,800 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

8,800 円(税込)

購入する

商品紹介

本書は現在治療にかかわるスタッフや，これから資格取得を目指す医療従事者に向けた，補助人工心臓治療チームのためのガイドブックである。今回の改訂では，補助人工心臓治療の歴史，保険償還などの背景，国内外の最新の補助人工心臓治療情報を追加するとともに，今の日本の補助人工心臓治療をリードする認定施設チームの実際について解説した。実際に使用しているチェックシートやスライドなどを多数引用し，実践的なチーム医療が学べるようになっている。

目次

  • I　補助人工心臓の基本知識を理解する！
    　1. 心不全の理解と基本治療
    　2. 補助循環の位置づけ
    　3. 補助人工心臓の開発と原理
    　4. 補助人工心臓治療の社会基盤・施設認定基準を知る
    　5. 補助人工心臓の種類

    II　補助人工心臓の適応・装着手技・周術期管理を理解する！
    　1. 補助人工心臓の適応
    　2. 人工心臓手術の周術期（術前・術後）管理
    　3. 植込型補助人工心臓装着手術（総論）
    　4. 心臓移植手術時の補助人工心臓脱着手技
    　5. 補助人工心臓装着・交換手術における体外循環のポイント
    　6. 体外設置型補助人工心臓の患者トレーニング・長期院内管理の要点
    　7. 創部管理・ドライブライン管理・メンタルヘルスケア
    　8. リハビリテーション
    　9. 植込型補助人工心臓患者の退院に向けての準備と実際
    　10. 遠隔期（退院後遠隔期）合併症と対策
    　11.植込型LVAD症例の在宅治療のQOL向上に向けて
    　12. Bridge to recovery　補助人工心臓離脱
    　13. 補助人工心臓治療成績
    　14. 小児における補助人工心臓治療

    III　補助人工心臓の特徴と各セットアップ・管理のポイント！
    　1. ニプロ補助人工心臓
    　2. AB5000
    　3. Berlin Heart EXCOR
    　4. EVAHEART・EVAHEART2
    　5. HeartMate II
    　6. HeartMate3TM
    　7. Jarvik 2000
    　8. Heartware HVAD
    　9. IMPELLA

    IV　人工心臓治療の今後の課題について
    　1. 完全埋込型LVAD（fully implantable LVAD）の開発
    　2. Destination Therapy の臨床導入
    　　　～わが国における植込型補助人工心臓DT適応適正化の考え方～
    　3. 植込型LVAD：終末期医療・緩和医療
    　4. 補助人工心臓と再生治療

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

I 補助人工心臓の基本知識を理解する !

P.21 掲載の参考文献
1) Stuckey JH, Newman MM, Dennis C, et al : The use of the heart-lung machine in selected cases of acute myocardial infarction. Surg Forum 8 : 342-344, 1957.
PubMed
2) Kantrowitz A, Tjonneland S, Freed PS, et al : Initial clinical experience with intra-aortic balloon pumping in cardiogenic shock. JAMA 203 : 135, 1968.
 
3) Bregman D, Casarella WJ : Percutaneous intra-aortic balloon pumping : Initial experience. Ann Thorac Surg 29 : 153-155, 1980.
PubMed
4) Phillips SJ, Ballentine B, Slonine D, et al : Percutaneous initiation of cardiopulmonary bypass. Ann Thorac Surg 36 : 223-225, 1983.
PubMed
5) Clauss RH, Birtwell WC, Albertal G, et al : Assisted circulation. I. The arterial counterpulsator. J Thorac Cardiovasc Surg 41 : 447-458, 1961.
PubMed
6) Moulopoulos SD, Topaz SR, Kolff WJ : Extracorporeal assistance to the circulation and intraaortic balloon pumping. Trans Am Soc Artif Intern Organs 8 : 85-89, 1962.
 
7) Philipp A, Arlt M, Amann M, et al : First experience with the ultra compact mobile extracorporeal membrane oxygenation system Cardiohelp in interhospital transport. Interact Cardiovasc Thorac Surg 12 : 978-981, 2011.
PubMed
8) Eugene J, McColgan SJ, Moore-Jeffries EW, et al : Cardiac assist by extracorporeal membrane oxygenation with in-line left ventricular venting. Trans Am Soc Artif Intern Organs 30 : 99-102, 1984.
PubMed
9) 許俊鋭, 元山猛, 尾本良三, ほか : 開心術後重症心不全症例と心原性ショックを伴った非手術症例に対する補助循環治療, 人工臓器 22 : 286-291, 1993.
 
10) Patel SM, Lipinski J, Al-Kindi SG, et al : Simultaneous Venoarterial Extracorporeal Membrane Oxygenation and Percutaneous Left Ventricular Decompression Therapy with Impella Is Associated with Improved Outcomes in Refractory Cardiogenic Shock. ASAIO J 2018 Feb 27
 
11) Liotta D, Hall CW, Henly WS, et al : Prolonged assisted circulation during and after cardiac or aortic surgery. Prolonged partial left ventricular bypass by means of intracorporeal circulation. Am J Cardiol 12 : 399, 1963.
PubMed
12) 古田昭一, 鰐淵康彦, 井野隆史, ほか : 補助人工心臓の臨床. 人工臓器 10 : 657-660, 1981.
 
13) Starnes VA, Oyer PE, Portner PM, et al : Isolated left ventricular assist as bridge to cardiac transplantation. J Thorac Cardiovasc Surg 96 : 62-71, 1988.
PubMed
14) Gemmato CJ, Forrester MD, Myers TJ, et al : Thirty-five years of mechanical circulatory support at the Texas Heart Institute : an updated overview. Tex Heart Inst J 32 : 168-177, 2005.
PubMed
15) Westaby S, Banning AP, Jarvik R, et al : First permanent implant of the Jarvik 2000 Heart. Lancet 356 : 900-903, 2000.
PubMed
16) Rose EA, Gelijns AC, Moskowitz AJ, et al : Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 345 : 1435-1443, 2001.
PubMed
17) Griffith BP, Kormos RL, Borovetz HS, et al : HeartMate II left ventricular assist system : from concept to first clinical use. Ann Thorac 71 : S116-120, 2001.
PubMed
18) Nishinaka T, Schima H, Roethy W, et al : The DuraHeart VAD, a magnetically levitated centrifugal pump : the University of Vienna bridge-to-transplant experience. Circ J 70 : 1421-1425, 2006.
 
19) Yamazaki K, Saito S, Kihara S, et al : Completely pulsatile high flow circulatory support with a constant-speed centrifugal blood pump : mechanisms and early clinical observations. Gen Thorac Cardiovasc Surg 55 : 158-162, 2007.
PubMed
20) Slaughter MS, Rogers JG, Milano CA, et al ; HeartMate II Investigators ; Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 361 : 2241-2251, 2009.
PubMed
21) Zimpfer D, Netuka I, Schmitto JD, et al : Multicentre clinical trial experience with the HeartMate 3 left ventricular assist device : 30-day outcomes. Eur J Cardiothorac Surg 50 : 548-554, 2016.
PubMed
22) Dennis C, Hall DP, Moreno JR, et al : Left atrial cannulation without thoracotomy for total left heart bypass. Acta Chir Scand 123 : 267-279, 1962.
PubMed
23) Frazier OH, Wampler RK, Duncan JM, et al : First human use of the Hemopump, a catheter-mounted ventricular assist device. Ann Thorac Surg 49 : 299-304, 1990.
PubMed
24) Kyo S, Motoyama T, Miyamoto N, et al : Percutaneous introduction of left atrial cannula for left heart bypass : Utility of biplane transesophageal echocardiographic guidance for transseptal puncture. Artificial organ 16 : 386-391, 1992.
PubMed
25) Brinkman WT, Rosenthal JE, Eichhorn E, et al : Role of a percutaneous ventricular assist device in decision making for a cardiac transplant program. Ann Thorac Surg 88 : 1462-1466, 2009.
PubMed
26) Meyns B, Dens J, Sergeant P, et al : Initial experiences with the Impella device in patients with cardiogenic shock-Impella support for cardiogenic shock. Thorac Cardiovasc Surg 51 : 312-317, 2003.
PubMed
27) Van Mieghem NM, Daemen J, den Uil C, et al : Design and principle of operation of the HeartMate PHP (percutaneous heart pump). EuroIntervention 13 : 1662-1666, 2018.
PubMed
28) Cooley DA, Liotta D, Hallman GL, et al : Orthotopic cardiac prosthesis for two-staged cardiac replacement. Am J Cardiol 24 : 723-730, 1969.
PubMed
29) Joyce LD, DeVries WC, Hastings WL, et al : Response of the human body to the first permanent implant of the Jarvik-7 Total Artificial Heart. Trans Am Soc Artif Intern Organs 29 : 81-87, 1983.
 
30) Dowling RD, Gray LA Jr, Etoch SW, et al : Initial experience with the AbioCor implantable replacement heart system. J Thorac Cardiovasc Surg 127 : 131-141, 2004.
PubMed
31) Spencer FC, Eiseman B, Trinkle JK, et al : Assisted circulation for cardiac failure following intra-cardiac surgery with cardiopulmonary bypass. J Thorac Cardiovasc Surg 49 : 56, 1965.
 
32) DeBakey ME : Left ventricular bypass pump for cardiac assistance. Clinical experience. Am J Cardiol 27 : 3-11, 1971.
PubMed
33) Copeland JG, Levinson MM, Smith R, et al : The total artificial heart as a bridge to transplantation : A report of two cases. JAMA 256 : 2991, 1986.
PubMed
34) Norman JC, Brook MI, Cooley DA, et al : Total support of the circulation of a patient with post-cardiotomy stone-heart syndrome by a partial artificial heart (ALVAD) for 5 days followed by heart and kidney transplantation. Lancet 1 (8074) : 1125-1127, 1978.
PubMed
P.24 掲載の参考文献
1) 高本真一, 木本誠二 : 心臓性ショック犬における大動脈バルーンパンピングと酸素化装置のないV-Aバイパス併用法の血行動態に及ぼす効果. 日胸外会誌 27 : 902-909, 1979.
 
2) Ma P, Zhang Z, Song T, et al : Combining ECMO with IABP for the treatment of critically III adult heart failure patients. Heart Lung Circ 23 : 363-368, 2014.
 
3) Cheng R, Hachamovitch R, Makkar R, et al : Lack of Survival Benefit Found With Use of Intraaortic Balloon Pump in Extracorporeal Membrane Oxygenation : A Pooled Experience of 1517 Patients. J Invasive Cardiol 27 : 453-458, 2015.
PubMed
4) Sauren LD, Reesink KD, Selder JL, et al : The acute effect of intra-aortic balloon counterpulsation during extracorporeal life support : an experimental study. Artif Organs 31 : 31-38, 2007.
PubMed
5) Eugene J, McColgan SJ, Moore-Jeffries EW, et al : Cardiac assist by extracorporeal membrane oxygenation with in-line left ventricular venting. Trans Am Soc Artif Intern Organs 30 : 99-102, 1984.
PubMed
6) Patel SM, Lipinski J, Al-Kindi SG, et al : Simultaneous Venoarterial Extracorporeal Membrane Oxygenation and Percutaneous Left Ventricular Decompression Therapy with Impella Is Associated with Improved Outcomes in Refractory Cardiogenic Shock. ASAIO J 2018.
 
P.33 掲載の参考文献
1) T. Yamane : Mechanism of Artificial Heart. Springer 1-77, 2016.
 
2) 山根隆志 : 連続流ポンプの原理. 医学の歩み Vol.262 (1), 2017.
 
3) ターボ機械協会編 : ターボポンプ新改訂版. 日本工業出版, 2007.
 
4) 山根隆志, 丸山修, 西田正浩, 小阪亮 : モノピボット遠心血液ポンプの実用化開発-製品につながる医工連携とは-. 産業技術総合研究所シンセシオロジー Vol.5 (1) : 16-24, 2012.
 
5) 医薬品医療機器総合機構 : IMPELLA循環補助用ポンプカテーテル, 審査結果報告書 2016. 6. 29
 
P.36 掲載の参考文献
1) 許俊鋭 : 循環器診療の質の向上とそれを阻害するもの 埋め込み型LVASの臨床導入 : ノバコア保険償還の経緯と今後の課題. Cardiovascular Med-Surg 17 : 87-91, 2005.
 
2) 次世代医療機器評価指標検討会 (厚生労働省)/医療機器開発ガイドライン評価検討委員会 (経済産業省) 合同検討会について (http://www.aist.go.jp/pdf/aist_j/iryoukiki/2009/introduction-GuideLineAIST.pdf)
 
3) 経済産業省 : 体内埋め込み型能動型機器分野 (高機能人工心臓システム) 開発ガイドライン 2007 (http://www.meti.go.jp/policy/mono_info_service/service/iryou_fukushi/downloadfiles/200705-2.pdf)
 
4) 厚生労働省 : 次世代医療機器評価指標の公表について, 次世代型高機能人工心臓の臨床評価のための評価指標, 薬食機発第0404002号, 平成20年4月4日.
 
5) 補助人工心臓治療関連学会協議会 : 植込型補助人工心臓の使用に係る体制等の基準案について. 日本臨床補助人工心臓研究会HP (http://www.jacvas.com/application/2/standard)
 
6) 医薬品医療機器総合機構 : トラッキング医療機器のデータ収集評価システム構築に関する検討について (https://www.pmda.go.jp/safety/surveillance-analysis/0009.html)
 
P.39 掲載の参考文献
1) 経済産業省 : 体内埋め込み型能動型機器分野 (高機能人工心臓システム) 開発ガイドライン 2007 2007年5月.
 
2) 厚生労働省 : 次世代医療機器評価指標の公表について, 次世代型高機能人工心臓の臨床評価のための評価指標 薬食機発第0404002号, 2008年4月4日.
 
3) Yamane T, Kyo S, Matsuda H, et al : Japanese Guidance for Ventricular Assist Devices/Total Artificial Hearts. Artificial Organs 34 : 699-702, 2010.
PubMed
P.46 掲載の参考文献
1) 許俊鋭 : 循環器診療の質の向上とそれを阻害するもの 埋め込み型LVASの臨床導入 : ノバコア保険償還の経緯と今後の課題. Cardiovascular Med-Surg 17 (2) ; 87-91, 2005.
 
2) 補助人工心臓治療関連学会協議会 : 植込型補助人工心臓の使用に係る体制等の基準案について. 日本臨床補助人工心臓研究会HP (http://www.jacvas.com/application/2/standard)
 
3) 診療点数早見表 2016年4月版 [医科]. 医学通信社, 2016.
 
P.61 掲載の参考文献
1) 田倉智之 : "医療経済 (83)". インターベンション必携 (専門医試験向け手引書). 心血管インターベンション学会 東京. 215-219, 2013.
 
2) Takura T : An Evaluation of Clinical-economics and Cases of Cost-effectiveness. Intern Med 2017.
PubMed
3) Takura T, Kyo S, Ono M, et al : Preliminary report on the cost-effectiveness of ventricular assist devices. J Artif Organs 19 : 37-43, 2015.
 
4) 田倉智之, 許俊鋭, 澤芳樹 : 埋め込み型補助人工心臓がもたらす経済効果. 人工臓器 41 : 93-98, 2012
 
P.67 掲載の参考文献
1) Tarzia V : Surgical implantation of the CardioWest Total Artificial Heart. Ann Cardiothorac Surg 3 : 624-625, 2014.
PubMed
2) Vranckx P, Foley DP, de Feijter PJ, et al : Clinical introduction of the Tandemheart, a percutaneous left ventricular assist device, for circulatory support during high-risk percutaneous coronary intervention. Int J Cardiovasc Intervent 5 : 35-39, 2003.
PubMed
3) Meyns B, Dens J, Sergeant P, et al : Initial experiences with the Impella device in patients with cardiogenic shock-Impella support for cardiogenic shock.Thorac Cardiovasc Surg 51 : 312-317, 2003.
PubMed
4) Jensen PB, Kann SH, Veien KT, et al : Single-centre experience with the Impella CP, 5.0 and RP in 109 consecutive patients with profound cardiogenic shock. Eur Heart J Acute Cardiovasc Care 7 : 53-61, 2018.
 
5) Ravichandran AK, Baran DA, Stelling K, et al : Outcomes with the Tandem Protek Duo Dual-Lumen Percutaneous Right Ventricular Assist Device. ASAIO J 2017.
 

II 補助人工心臓の適応・装着手技・周術期管理を理解する !

P.75 掲載の参考文献
1) Imamura T, Kinugawa K, Nitta D, et al : Should cardiac resynchronization therapy be a rescue therapy for inotrope-dependent patients with advanced heart failure? J Card Fail 21 : 535-538, 2015.
PubMed
2) Kirklin JK, Pagani FD, Kormos RL, et al ; Eighth annual INTERMACS report : Special focus on framing the impact of adverse events. J Heart Lung Transplant 36 : 1080-1086, 2017.
PubMed
P.78 掲載の参考文献
1) Imamura T, Kinugawa K, Shiga T, et al : Novel risk scoring system with preoperative objective parameters gives a good prediction of 1-year mortality in patients with a left ventricular assist device. Circ J 76 : 1895-1903, 2012.
PubMed
P.83 掲載の参考文献
1) Imamura T, Kinugawa K, Hatano M, et al : Acute pulmonary vasoreactivity test with sildenafil or nitric monoxide before left ventricular assist device implantation. J Artif Organs 16 : 389-392, 2013.
PubMed
2) Hatano M, Kinugawa K, Shiga T, et al : Less frequent opening of the aortic valve and a continuous flow pump are risk factors for postoperative onset of aortic insufficiency in patients with a left ventricular assist device. Circ J 75 : 1147-1155, 2011.
 
3) Cowger J, Sundareswaran K, Rogers JG, et al : Predicting survival in patients receiving continuous flow left ventricular assist devices : the HeartMate II risk score. J Am Coll Cardiol 61 : 313-321, 2013.
PubMed
4) Adamo L, Nassif M, Tibrewala A, et al : The Heartmate Risk Score predicts morbidity and mortality in unselected left ventricular assist device recipients and risk stratifies INTERMACS class 1 patients. JACC Heart Fail 3 : 283-290, 2015.
PubMed
5) Shah KB, Starling RC, Rogers JG, et al : Left ventricular assist devices versus medical management in ambulatory heart failure patients : An analysis of INTERMACS Profiles 4 and 5 to 7 from the ROADMAP study. J Heart Lung Transplant 37 : 706-714. 2017.
PubMed
6) Imamura T, Kinugawa K, Hatano M, et al : Status 2 patients had poor prognosis without mechanical circulatory support. Circ J 78 : 1396-1404, 2014.
PubMed
7) Imamura T, Kinugawa K, Nitta D, et al : Novel scoring system using cardiopulmonary exercise testing predicts prognosis in heart failure patients receiving guideline-directed medical therapy. Circ J 79 : 1068-1075, 2015.
PubMed
8) Imamura T, Kinugawa K, Shiga T, et al : Early decision for a left ventricular assist device implantation is necessary for patients with modifier A. J Artif Organs 15 : 301-304, 2012.
 
P.85 掲載の参考文献
1) Imamura T, Kinugawa K, Kinoshita O, et al : High pulmonary vascular resistance in addition to low right ventricular stroke work index effectively predicts biventricular assist device requirement. J Artif Organs 19 : 44-53, 2016.
 
2) Kang G, Ha R, Banerjee D : Pulmonary artery pulsatility index predicts right ventricular failure after left ventricular assist device implantation. J Heart Lung Transplant 35 : 67-73, 2016.
PubMed
3) Kirklin JK, Pagani FD, Kormos RL, et al : Eighth annual INTERMACS report : Special focus on framing the impact of adverse events. J Heart Lung Transplant 36 : 1080-1086, 2017.
PubMed
4) Shehab S, Macdonald PS, Keogh AM, et al : Long-term biventricular HeartWare ventricular assist device support--Case series of right atrial and right ventricular implantation outcomes. J Heart Lung Transplant 35 : 466-473, 2016.
PubMed
5) Imamura T, Kinugawa K, Kato N, et al : Late-onset right ventricular failure in patients with preoperative small left ventricle after implantation of continuous flow left ventricular assist device. Circ J 78 : 625-633, 2014.
PubMed
P.88 掲載の参考文献
1) Nishimura M, et al : Importance of luxury flow for critically ill patients receiving a left ventricular assist system. J Artif Organs 9 : 209-213, 2006.
PubMed
P.89 掲載の参考文献
1) Nishimura M, et al : Importance of luxury flow for critically ill patients receiving a left ventricular assist system. J Artif Organs 9 : 209-213, 2006.
PubMed
P.91 掲載の参考文献
1) Pagani FD, Miller LW, Russell SD, et al : Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. J Am Coll Cardiol 54 : 312-321, 2009.
PubMed
2) Kumar A : Optimizing antimicrobial therapy in sepsis and septic shock. Crit Care Clin 25 : 733-751, 2009.
PubMed
3) Simon D, Fischer S, Grossman A et al : Left ventricular assist device-related infection : treatment and outcome. Clin Infect Dis 40 : 1108-1115, 2005.
PubMed
P.94 掲載の参考文献
1) Nakamura K, Kawahito K : Erythrocyte-protective effect of sarpogrelate hydrochloride (Anplag(R)), a selective 5-HT2 receptor antagonist : an in vitro study. J Artif Organs 13 : 178-181, 2010.
 
P.96 掲載の参考文献
1) Trachtenberg BH, Cordero-Reyes AM, Aldeiri M, et al : Persistent blood stream infection in patients supported with a continuous-flow left ventricular assist device is associated with an increased risk of cerebrovascular accidents. J Card Fail 21 : 119-125, 2015.
PubMed
2) 日本脳卒中学会 脳卒中ガイドライン [追補2017] 委員会 : 脳卒中ガイドライン 2015 [追補2017].
 
3) 峰松一夫, 飯原弘二, 小笠原邦昭, ほか : 経皮経管的脳血栓回収機器 適正使用指針 (第2版). 脳卒中 37 : 259-279, 2015.
 
P.106 掲載の参考文献
1) Yoshitake S, Kinoshita O, Nawata K, et al : Novel driveline route for prevention from driveline infection : Triple tunnel method. J Cardiol 2018 : https://doi.org/10.1016/j. jjcc. 2018. 04. 003
 
2) 小野稔 : 補助人工心臓脱血管装着術のコツ. 胸部外科 64 : 284, 2011.
 
3) Adamson RM, Dembitsky WP, Baradarian S, et al : Aortic valve closure associated with HeartMate left ventricular device support : technical considerations and long-term results. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 30 : 576-582, 2011.
PubMed
4) Slaughter MS, Pagani FD, Rogers JG, et al : Clinical management of continuous-flow left ventricular assist devices in advanced heart failure. J Heart Lung Transplant 29 : S1-39, 2010.
PubMed
5) Feldman D, Pamboukian SV, Teuteberg JJ, et al : The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support : Executive summary. J Heart Lung Transplant 32 : 157-187, 2013.
 
P.112 掲載の参考文献
1) 今田竜之, 林行雄 : 心臓移植の麻酔. 「心臓移植」 (松田暉, 監修, 布田伸一, 福嶌教偉, 編). シュプリンガージャパン, 東京, p173-178, 2011.
 
2) 北村惣一郎 : bicaval法とその変法. 「心臓移植」 (松田暉, 監修, 布田伸一, 福嶌教偉, 編). シュプリンガージャパン, 東京, p169-172, 2011.
 
3) Kitamura S, Nakatani T, Bando K : Modification of bicaval anastomosis technique for orthotopic heart transplantation. Ann Thorac Surg 72 : 1405-1406, 2001.
PubMed
P.130 掲載の参考文献
1) 坂口平馬 : 循環管理 : 小児重症心不全とVAD. ICUとCCU 41 : 243-247, 2017.
Medical*Online
2) 天尾理恵 : 小児用体外式補助人工心臓装着患者のリハビリテーションの経験. 心臓リハビリーション (JJCR) 21 : 100-103, 2016.
 
3) 遠藤美代子 : ドライブライン管理. 高本眞一監, 許俊鋭編, 心不全外科治療の要点と盲点, 文光堂, 東京, 2012, p241-244.
 
P.141 掲載の参考文献
1) 天尾理恵, 山口正貴, 安井健, ほか : 植込型補助人工心臓装着患者の運動能力の推移～術前から術後自宅退院12ヶ月後までの経過～. 心臓リハビリテーション 22 : 286-292, 2016.
Medical*Online
2) Christiane M, Endri X, Thomas LM, et al : Exercise Performance During the First Two Years AfterLeft Ventricular Assist Device Implantation. ASAIO J 63 : 408-413, 2017.
 
3) Michel XL, Sara C, Gael D, et al : Left ventricular assist device : exercise capacity evolution and rehabilitation added value. Acta Cardiologica 28 : 1-8, 2017.
 
4) Susan MJ, Joshua LM, Justin MV, et al : Prospective Assessment of Frailty Using the Fried Criteria in Patients Undergoing Left Ventricular Assist Device Therapy. Am J Cardiol 120 : 1349-1354, 2017.
 
5) Blume ED, Rosenthal DN, Rossano JW, et al : Outcomes of children implanted with ventricular assist devices in the United States : First analysis of the Pediatric Interagency Registry for Mechanical Circulatory Support (PediMACS). J Heart Lung Transplant 35 : 578-584, 2016.
PubMed
P.169 掲載の参考文献
1) Jorde UP, Uriel N, Nahumi N, et al : Prevalence, significance, and management of aortic insufficiency in continuous flow left ventricular assist device recipients. Circ Heart Fail 7 : 310-319, 2014.
PubMed
2) Imamura T, Kinugawa K, Fujino T, et al : Aortic insufficiency in patients with sustained left ventricular systolic dysfunction after axial flow assist device implantation. Circ J 79 : 104-111, 2015.
PubMed
P.176 掲載の参考文献
1) Kimura M, Nawata K, Kinoshita O, et al : Readmissions after continuous flow left ventricular assist device implantation. J Artif Organs 20 : 311-317, 2017.
PubMed
2) Trachtenberg BH, Cordero-Reyes AM, Aldeiri M, et al : Persistent blood stream infection in patients supported with a continuous-flow left ventricular assist device is associated with an increased risk of cerebrovascular accidents. J Card Fail 21 : 119-125, 2015.
PubMed
P.177 掲載の参考文献
1) Nakatani T, Sase K, Oshiyama H, et al : Japanese registry for Mechanically Assisted Circulatory Support : First report. J Heart Lung Transplant 36 : 1087-1096, 2017.
PubMed
2) Maltais S, Kilic A, Nathan S, et al : PREVENtion of HeartMate II Pump Thrombosis Through Clinical Management : The PREVENT multi-center study. J Heart Lung Transplant 36 : 1-12, 2017.
PubMed
3) Uriel N, Morrison KA, Garan AR, et al : Development of a novel echocardiography ramp test for speed optimization and diagnosis of device thrombosis in continuous-flow left ventricular assist devices : the Columbia ramp study. J Am Coll Cardiol 60 : 1764-1775, 2012.
PubMed
P.178 掲載の参考文献
1) Eckman PM, John R : Bleeding and thrombosis in patients with continuous-flow ventricular assist devices. Circulation 125 : 3038-3047, 2012.
PubMed
2) Wang W, Zhu J, Lyu F, et al : omega-3 polyunsaturated fatty acids-derived lipid metabolites on angiogenesis, inflammation and cancer. Prostaglandins Other Lipid Mediat 113-115 : 13-20, 2014.
 
P.187 掲載の参考文献
1) Kirklin JK, Naftel DC, Pagani FD, et al : Seventh INTERMACS annual report : 15,000 patients and counting. J Heart Lung Transplant 34 : 1495-1504, 2015.
PubMed
2) Imamura T, Kinugawa K, Nitta D, et al : Readmission due to driveline infection can be predicted by new score by using serum albumin and body mass index during long-term left ventricular assist device support. J Artif Organ 18 : 120-127, 2015.
PubMed
3) Trachtenberg BH, Cordero-Reyes A, Elias B, et al : A review of infections in patients with left ventricular assist devices : prevention, diagnosis and management. Methodist Debakey Cardiovasc J 11 : 28-32, 2015.
 
4) Dimitri K, Michael ZT, Randall CS, et al : Percutaneous Lead Dysfunction in the HeartMate II Left Ventricular Assist Device. Ann Thorac Surg 97 : 1373-1378, 2014.
 
5) Nader M, Carmelo AM, Ranjit J, et al : Pump Replacement for Left Ventricular Assist Device Failure Can Be Done Safely and Is Associated With Low Mortality. Ann Thorac Surg 95 : 500-505, 2013.
 
P.190 掲載の参考文献
1) 診療点数早見表 2012年4月版 医学通信社 p.564.
 
P.192 掲載の参考文献
1) Aburjania N, Sherazi S, Tchantchaleishvili V, et al : Stopping Conventional Showering Decreases Pseudomonas Exit Site Infections in Left Ventricular Assist Device Patients. Int J Artif Organs 40 : 282-285, 2017.
PubMed
P.194 掲載の参考文献
1) Levine GN, Steinke EE, Bakaeen FG, et al : Sexual activity and cardiovascular disease : a scientific statement from the American Heart Association. Circulation 125 : 1058-1072, 2012.
PubMed
2) Samuels LE, Holmes EC, Petrucci R : Psychosocial and sexual concerns of patients with implantable left ventricular assist devices : a pilot study. J Thorac Cardiovasc Surg 127 : 1432-1435, 2004.
PubMed
3) Hasin T, Jaarsma T, Murninkas D, et al : Sexual function in patients supported with left ventricular assist device and with heart transplant. ESC Heart Fail 1 : 103-109, 2014.
PubMed
4) Merle P, Maxhera B, Albert A, et al : Sexual Concerns of Patients with Implantable Left Ventricular Assist Devices. Artif Organs 39 : 664-669, 2015.
PubMed
5) Makdisi G, Jan MY, Dungy-Poythress L, et al : Successful Delivery in a Patient With Left Ventricular Assist Device and Unplanned Pregnancy. Ann Thorac Surg 104 : e31-e33, 2017.
 
P.197 掲載の参考文献
1) Imamura T, Kinugawa K, Hatano M, et al : Preoperative beta-blocker treatment is a key for deciding left ventricular assist device implantation strategy as a bridge to recovery. J Artif Organs 17 : 23-32, 2014.
 
2) Imamura T, Kinugawa K, Nitta D, et al : Novel scoring system using postoperative cardiopulmonary exercise testing predicts future explantation of left ventricular assist device. Circ J 79 : 560-566, 2015.
PubMed
P.201 掲載の参考文献
1) Kimura M, Kinoshita O, Nishimura T, et al : Successful weaning from the DuraHeart with a low left ventricular ejection fraction. J Artif Organs 16 : 504-507, 2013.
PubMed
2) Yoshioka D, Toda K, Sakaguchi T, et al : Initial report of bridge to recovery in a patient with DuraHeart LVAD. J Artif Organs 16 : 386-388, 2013.
 
P.203 掲載の参考文献
1) 木下修, 小野稔 : 体外設置型補助人工心臓後の植込み型補助人工心臓装着術, 胸部外科領域における再手術-最近の動向. 胸部外科 66 : 690-695, 2013.
 
2) Hisagi M, Nishimura T, Ono M, et al : New pre-clotting method for fibrin glue in a nonsealed graft used in an LVAD : the KYO method. J Artif Organs 13 : 174-177, 2010.
 
P.205 掲載の参考文献
1) Cohn WE, Gregoric ID, Radovancevic B, et al : A felt plug simplifies left ventricular assist device removal after successful bridge to recovery. Journal Heart Lung Transplant 26 : 1209-1211, 2007.
PubMed
2) Potapov EV, Stepanenko A, Henning E, et al : A titanium plug simplifies left ventricular assist. J Heart lung Transplant 29 : 1316-1317, 2010.
 
3) Baldwin AC, Sandoval E, Letsou GV, et al : Surgical approach to continuous-flow left ventricular assist device explantation : A comparison of outcomes. J Thorac Cardiovasc Surg 151 : 192-198, 2016.
PubMed
P.209 掲載の参考文献
1) Pagani FD, Lynch W, Swaniker F, et al : Extracorporeal life support to left ventricular assist device bridge to heart transplant : A strategy to optimize survival and resource utilization. Circulation 100 (19 Suppl) : II 206-210, 1999.
 
2) den Uil CA, Akin S, Jewbali LS, et al : Short-term mechanical circulatory support as a bridge to durable left ventricular assist device implantation in refractory cardiogenic shock : a systematic review and meta-analysis. Eur J Cardiothorac Surg 52 : 14-25, 2017.
PubMed
3) Pawale A, Schwartz Y, Itagaki S, et al : Selective implantation of durable left ventricular assist devices as primary therapy for refractory cardiogenic shock. J Thorac Cardiovasc Surg 155 : 1059-1068, 2018.
PubMed
P.212 掲載の参考文献
1) Kirklin JK, Pagani FD, Kormos RL, et al : Eighth annual INTERMACS report : Special focus on framing the impact of adverse events. J Heart Lung Transplant 36 : 1080-1086, 2017.
PubMed
2) Mehra MR, Goldstein DJ, Uriel N, et al : Two-Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure. N Engl J Med. 2018.
PubMed
3) 日本胸部外科学会 : J-MACS Statistical Report 2017年10月 (http://www.jpats.org/uploads/uploads/files/J-MACS%20Statistical%20Report(2010年6月-2017年7月).pdf)
 
4) Nakatani T, Sase K, Oshiyama H, et al : Japanese registry for Mechanically Assisted Circulatory Support : First report. J Heart Lung Transplant 36 : 1087-1096, 2017.
PubMed
P.214 掲載の参考文献
1) Kirklin JK, Pagani FD, Kormos RL, et al : Eighth annual INTERMACS report : Special focus on framing the impact of adverse events. J Heart Lung Transplant 36 : 1080-1086, 2017.
PubMed
2) Mehra MR, Goldstein DJ, Uriel N, et al : Two-Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure. N Engl J Med. 2018.
PubMed
P.219 掲載の参考文献
1) Adachi I, Burki S, Zafar F, et al : Pediatric ventricular assist devices. J Thorac Dis 7 : 2194-2202, 2015.
PubMed
2) Hetzer R, Kaufmann F, Walter EMD. Paediatric mechanical circulatory support with Berlin Heart EXCOR : Development and outcome of a 23-year experience. Eur J Cardio-Thoracic Surg 50 : 203-210, 2016.
 
3) Fraser CD, Jaquiss RDB, Rosenthal DN, et al : Prospective trial of a pediatric ventricular assist device. N Engl J Med 367 : 532-541, 2012.
PubMed

III 補助人工心臓の特徴と各セットアップ・管理のポイント !

P.224 掲載の参考文献
1) Hisagi M, Nishimura T, Ono M, et al : New pre-clotting method for fibrin glue in a nonsealed graft used in an LVAD : the KYO method. J Artif Organs 13 : 174, 2010.
 
P.243 掲載の参考文献
1) Nguyen K : A technique for implanting outflow cannulas for Berlin Heart EXCOR ventricular assist device in small pediatric patients. J Thorac Cardiovasc Surg 142 : 223-224, 2011.
 
P.251 掲載の参考文献
1) Yamazaki K, Litwak P, Tagusari O, et al : An implantable centrifugal blood pump with a recirculating purge system (Cool-Seal system). Artif Organs 22 : 466-474, 1998.
PubMed
2) Yamazaki K, Saito S, Kihara S, et al : Completely pulsatile high flow circulatory support with a constant-speed centrifugal blood pump : mechanisms and early clinical obsavation. Gen Thorac Cardiovasc Surg 55 : 158-162, 2007.
PubMed
3) Ishihara K, Tanaka S, Fukukawa N, et al : Improved blood compatibility of segmented polyurethanes by polymeric additives having a phospholipid polar group. I. Molecular design of polymeric additives and their functions. J Biomed Mater Res 32 : 391-399, 1996.
 
4) 山嵜健二 : 体内植込型遠心ポンプEVAHEART : 循環冷却システムを用いた低温メカニカルシール (Cool-Seal system) の考案. 人工臓器 35 : 168-169, 2006.
 
P.261 掲載の参考文献
1) Yamazaki K, Saito S, Kihara S, et al : Completely pulsatile high flow circulatory support with a constant speed centrifugal blood pump : mechanisms and early clinical observation. Gen Thorac Cardiovasc Surg 55 : 158-162, 2007.
PubMed
2) Bartoli C, Kang J, Zhang D, et al : Left ventricular assist device design reduces von Willebrand factor degradation : A comparative study between the HeartMate II and the EVAHEART left ventricular assist system. Ann Thorac Surg 103 : 1239-1245, 2017.
PubMed
3) Ichihara Y, Nishinaka T, Komagamine M, et al. Preservation of von Willebrand factor multimers and function in patients with an EVAHEART centrifugal-type, continuous-flow left ventricular assist device. J Heart Lung Transplant 36 : 814-817, 2017.
PubMed
4) Saito S, Yamazaki K, Nishinaka T, et al : Post-approval study of a highly pulsed, low-shear-rate, continuous-flow, left ventricular assist device, EVAHEART : A Japanese multicenter study using J-MACS. J Heart Lung Transplant 33 : 599-608, 2014.
 
P.278 掲載の参考文献
1) Mehra MR, Goldstein DJ, Uriel N, et al : Two-Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure. N Engl J Med 378 : 1386-1395, 2018.
PubMed
P.286 掲載の参考文献
1) Uriel N, Morrison KA, Garan AR, et al : Development of a novel echocardiography ramp test for speed optimization and diagnosis of device thrombosis in continuous-flow left ventricular assist devices : the Columbia ramp study. J Am Coll Cardiol 60 : 1764-1775, 2012.
PubMed
2) Uriel N, Adatya S, Maly J, et al : Clinical hemodynamic evaluation of patients implanted with a fully magnetically levitated left ventricular assist device (HeartMate 3). J Heart Lung Transplant 36 : 28-35, 2017.
PubMed
P.295 掲載の参考文献
1) Mustafa Pac : Third Generation Ventricular Assist Device : Mid-Term Outcomes of the HeartWare HVAD in Pediatric Patients. Artificial Organs 42, 141-147, 2018.
PubMed

IV 人工心臓治療の今後の課題について

P.315 掲載の参考文献
1) Nienaber JJ, Kusne S, Riaz T, et al ; Mayo Cardiovascular Infections Study Group : Clinical manifestations and management of left ventricular assist device-associated infections. Clin Infect Dis 57 : 1438-1448, 2013.
 
2) Topkara VK, Kondareddy S, Malik F, et al : Infectious complications in patients with left ventricular assist device : etiology and outcomes in the continuous-flow era. Ann Thorac Surg 90 : 1270-1277, 2010.
PubMed
3) Pae WE, Connell JM, Adelowo A, et al ; Clinical Utility Baseline Study (CUBS) Group : Does total implantability reduce infection with the use of a left ventricular assist device? The LionHeart experience in Europe. J Heart Lung Transplant 26 : 219-229, 2007.
 
4) Frazier OH, Dowling RD, Gray LA Jr, et al : The total artificial heart : where we stand. Cardiology 101 : 117-121, 2004.
PubMed
5) 独立行政法人新エネルギー・産業技術総合開発機構研究評価委員会 : 「臨床応用に向けた体内埋込み型人工心臓システム」事後評価報告書 (平成18年3月) (http://www.nedo.go.jp/content/100096385.pdf)
 
P.319 掲載の参考文献
1) Rose EA, Gelijns AC, Moskowitz AJ, et al : Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 345 : 1435-1443, 2001.
PubMed
2) Slaughter MS, Rogers JG, Milano CA, et al ; HeartMate II Investigators : Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 361 : 2241-2251, 2009.
PubMed
P.323 掲載の参考文献
1) Swetz KM, Kamal AH, Matlock DD, et al : Preparedness planning before mechanical circulatory support : a"how-to"guide for palliative medicine clinicians. Journal of pain and symptom management 47 : 926-935 e6, 2014.
 
2) Nakagawa S, Yuzefpolskaya M, Colombo PC, et al : Palliative Care Interventions before Left Ventricular Assist Device Implantation in Both Bridge to Transplant and Destination Therapy. Journal of palliative medicine 2017.
PubMed
3) Lampert R, Hayes DL, Annas GJ, et al : HRS Expert Consensus Statement on the Management of Cardiovascular Implantable Electronic Devices (CIEDs) in patients nearing end of life or requesting withdrawal of therapy. Heart rhythm : the official journal of the Heart Rhythm Society 7 : 1008-1026, 2010.
PubMed
4) Caldwell PH, Arthur HM, Demers C : Preferences of patients with heart failure for prognosis communication. The Canadian journal of cardiology 23 : 791-796, 2007.
PubMed
P.327 掲載の参考文献
1) Shimizu T, Yamato M, Kikuchi A, et al : Two-dimensional manipulation of cardiac myocyte sheets utilizing temperature-responsive culture dishes augments the pulsatile amplitude. Tissue engineering 7 : 141-151, 2001.
PubMed
2) Miyagawa S, Saito A, Sakaguchi T, et al : Impaired Myocardium Regeneration With Skeletal Cell Sheets-A Preclinical Trial for Tissue-Engineered Regeneration Therapy. Transplantation 90 : 364-372, 2010.
 
3) Sawa Y, Miyagawa S, Sakaguchi T, et al : Tissue engineered myoblast sheets improved cardiac function sufficiently to discontinue LVAS in a patient with DCM : report of a case. Surg Today 42 : 181-184, 2012.
 
4) Miyagawa S. Domae K. Sawa Y, et al : Phase I Clinical Trial of Autologous Stem Cell-Sheet Transplantation Therapy for Treating Cardiomyopathy. J Am Heart Assoc 6 : e003918, 2017.
 
5) Sawa Y, Yoshikawa Y, Toda K, et al : Safety and Efficacy of Autologous Skeletal Myoblast Sheets (TCD-51073) for the Treatment of Severe Chronic Heart Failure Due to Ischemic Heart Disease. Circulation journal : official journal of the Japanese Circulation Society 79 : 991-999, 2015.
PubMed

書評

最近チェックした商品履歴

Loading...